Article
Taming the mucosal immune response in Crohn's disease.
Best practice & research. Clinical gastroenterology - 1 Dec 2002
van Deventer S J H
Abstract excerpt
New effective therapeutic strategies for inflammatory bowel disease are based on recent knowledge of the regulation of the immune response. Specific defects of innate immunity, such as the NOD2 mutation in a subset of patients with Crohn's disease, have been associated with inflammatory bowel disease and provide new therapeutic targets. The ultimate therapeutic goal is the complete restoration of the mucosal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
